Preclinical News and Research

RSS
Millennium and Takeda initiate TAK-700 Phase III clinical trial in advanced prostate cancer

Millennium and Takeda initiate TAK-700 Phase III clinical trial in advanced prostate cancer

Study identifies promising therapy to overcome limitation in brain's ability to recover function after stroke

Study identifies promising therapy to overcome limitation in brain's ability to recover function after stroke

Bolder BioTechnology receives $1.2 million in Qualifying Therapeutic Discovery Project Grants

Bolder BioTechnology receives $1.2 million in Qualifying Therapeutic Discovery Project Grants

Bristol-Myers Squibb and Simcere partner to co-develop oncology compound

Bristol-Myers Squibb and Simcere partner to co-develop oncology compound

Synageva receives $2.3 million under QTDP program

Synageva receives $2.3 million under QTDP program

Regulus receives $488,989 grant under QTDP program

Regulus receives $488,989 grant under QTDP program

Alnylam third quarter revenue increases from $24.2 million to $27.7 million

Alnylam third quarter revenue increases from $24.2 million to $27.7 million

GTx receives $1.2 million under QTDP program

GTx receives $1.2 million under QTDP program

Safeguard Scientifics third quarter aggregate revenue of partner companies increases 73% to $109.6 million

Safeguard Scientifics third quarter aggregate revenue of partner companies increases 73% to $109.6 million

EUREKA program confirms ability of HIFU technology to deliver cancer drugs

EUREKA program confirms ability of HIFU technology to deliver cancer drugs

Amgen outlines key recommendations for implementing approval pathway for biosimilars

Amgen outlines key recommendations for implementing approval pathway for biosimilars

BioCryst receives $1.1 million in grants under QTDP program

BioCryst receives $1.1 million in grants under QTDP program

CONRAD receives $5 million award from USAID

CONRAD receives $5 million award from USAID

Avila presents results of AVL-192 preclinical studies for HCV infection at AASLD Meeting

Avila presents results of AVL-192 preclinical studies for HCV infection at AASLD Meeting

ImmunoGen to present clinical data of lead compounds at EORTC-NCI-AACR Symposium

ImmunoGen to present clinical data of lead compounds at EORTC-NCI-AACR Symposium

BioCancell reports results of BC-819 Phase I/IIa clinical trial for pancreatic cancer

BioCancell reports results of BC-819 Phase I/IIa clinical trial for pancreatic cancer

CytRx receives nontaxable grant under Qualifying Therapeutic Discovery Project Program

CytRx receives nontaxable grant under Qualifying Therapeutic Discovery Project Program

Inviragen receives two grants to develop dengue and chikungunya vaccines

Inviragen receives two grants to develop dengue and chikungunya vaccines

Pro-Pharmaceuticals awarded $489,000 in federal grants under Qualifying Therapeutic Discovery Project

Pro-Pharmaceuticals awarded $489,000 in federal grants under Qualifying Therapeutic Discovery Project

Palatin receives $978,000 in grants under PPACA

Palatin receives $978,000 in grants under PPACA

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.